Christopher Fowler

West Virginia University — United States

Medicine · Health Sciences

49h-index9.3kcitations312works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(134), Dementia and Cognitive Impairment Research(107), Neurological Disease Mechanisms and Treatments(14), Functional Brain Connectivity Studies(13), Neuroinflammation and Neurodegeneration Mechanisms(12)

Publications310 total

Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderly
Alzheimer s Research & Therapy·2025Open Access
Multivariate models using NULISAseq and plasma p‐tau217 for staging Alzheimer's disease
Alzheimer s & Dementia·2025· 3 citedOpen Access
An Indicator Cell Assay-based Multivariate Blood Test for Early Detection of Alzheimer’s Disease
2025Open Access
Combining Lumipulse p‐tau217 and Aβ42/40 as confirmatory tests for Aβ positivity prior to disease‐modifying therapy
Alzheimer s & Dementia·2025· 3 citedOpen Access
Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases
Scientific Reports·2025· 2 citedOpen Access
Multiomics analysis to evaluate the enrichment of extracellular vesicles from human plasma
Journal of Lipid Research·2025· 3 citedOpen Access
Association of plastic-associated chemicals with Alzheimer's disease amyloid-β and cognitive status
Journal of Alzheimer s Disease·2025· 2 cited
The generation, propagation, and impact of magnetosonic waves in the Mars magnetosphere: analysis of global hybrid simulations
2025Open Access
Transatlantic Slavery, Landownership, and Enclosure in England, 1738–1836
Liverpool University Press eBooks·2025
Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·2025Open Access
Amyloid-β protein precursor fragments in urine: Potential biomarkers for the early detection of mild cognitive impairment and dementia
Journal of Alzheimer s Disease·2025· 1 cited
Diagnostic performance of plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non‐AD dementias: An international multi‐center study
Alzheimer s & Dementia·2025· 10 citedOpen Access
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias
2025Open Access
Evaluation of Plasma pTau217 plus Abeta42/40, and pTau217/Abeta42 Ratio as Confirmatory Tests for Amyloid Pathology in Alzheimer’s Disease (AD) (N4.003)
Neurology·2025· 1 cited
Alzheimer’s disease biological PET staging using plasma p217+tau
Communications Medicine·2025· 6 citedOpen Access
Development and Validation of a Tool to Predict Onset of Mild Cognitive Impairment and Alzheimer Dementia
JAMA Network Open·2025· 6 citedOpen Access
Alpha-synuclein is increased in erythrocytes in Parkinson’s Disease cases
2024Open Access
Early identification of participants at risk of cognitive decline: An online tool for patient prediction of cognitive decline
Alzheimer s & Dementia·2024Open Access
Association of basal forebrain atrophy with cognitive decline in early Alzheimer’s disease
Alzheimer s & Dementia·2024Open Access
Comparing plasma Aβ42/40 and pTau217 to predict Amyloid‐β status across the Alzheimer’s disease continuum
Alzheimer s & Dementia·2024Open Access
page 1 of 16Next →

Frequent Co-authors

Colin L. Masters(39), Victor L. Villemagne(27), Ralph N. Martins(26), Christopher C. Rowe(22), James D. Doecke(21), David Ames(18), Stephanie R. Rainey‐Smith(16), Ashley I. Bush(14), Paul Maruff(14), Alan Rembach(13), Simon M. Laws(13), Kevin Taddei(12), Qiao‐Xin Li(10), Vincent Doré(9), Kelly Pertile(9), Rebecca Rumble(9), Brett Trounson(9), Blaine R. Roberts(8), Steven Collins(8), Pierrick Bourgeat(8)